A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation
NCT06772181
Summary
This clinical trial evaluates a digital health intervention for improving symptoms and physical activity among patients with breast cancer undergoing radiation. Cancer-related fatigue is common and strongly associated with quality of life during and after treatment. Increasing emphasis on early symptom detection and management has prompted initiatives to collect patient-reported fatigue from all patients during treatment. Mind-body interventions including physical activity and yoga are recommendations to treat fatigue and comorbid (coexisting) symptoms. Lower socioeconomic status has not only been associated with higher rates of physical inactivity but also with perceptions that it could negatively impact fatigue and quality of life during treatment. A virtual mind-body program called Integrative Medicine at Home (IM@Home) includes cardio fitness and yoga classes in a bundled intervention that has demonstrated decreased fatigue, depression, insomnia, and symptom distress among patients undergoing breast radiation. The IM@Home program may also increase physical activity among patients with breast cancer undergoing radiation.
Eligibility
Inclusion Criteria: * Age ≥ 18 years old. * Ability to understand English, or has a caregiver who understands English. * Ability to understand and willingness to sign a written informed consent document, virtually or in-person. * Current breast cancer diagnosis. * Currently receiving radiation with curative intent (including partial breast, whole breast, or regional nodal radiation). Exclusion Criteria: * Patients who are non-English speaking that would prevent their participation in IM@Home.
Conditions3
Locations2 sites
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06772181